台股 » 個股 » 智擎 » 籌碼相關 » 融資融券與借券

智擎

(4162)
可現股當沖
  • 股價
    93.6
  • 漲跌
    ▼0.5
  • 漲幅
    -0.53%
  • 成交量
    318
  • 產業
    上櫃 生技醫療類股
  • 302人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智擎 (4162) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

智擎 (4162) 融資融券與借券

智擎 (4162) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
05/22277,64721-360.02000.0894.1-1.05%415
05/2117,62020.92-290.02000.1295.1-1.86%454
05/2067,61920.92-2110.03000.1496.9-1.02%802
05/17597,61320.96130.0480.560.1797.92.94%1,432
05/16-177,55420.74070.0220.260.0995.11.28%777
05/15227,57120.79-270.0210.180.0993.9-0.42%550
05/14-487,54920.73490.0220.130.1294.31.84%1,501
05/13767,59720.86150.01000.0792.6-0.75%319
05/10117,52120.65-140.01000.0593.30.00%219
05/09-277,51020.62-150.01000.0793.3-0.74%251
05/08-987,53720.7-260.02000.08941.29%349
05/07-107,63520.96280.02000.192.8-0.64%270
05/06-947,64520.99-160.02000.0893.4-0.43%348
05/03-207,73921.25-170.02000.0993.8-1.16%247
05/02-357,75921.3280.02000.194.91.28%504
04/30177,79421.4-260.0272.470.0893.7-1.68%283
04/29307,77721.35580.0210.130.195.34.15%764
04/26627,74721.27030.01000.0491.50.99%318
04/25237,68521.1030.01000.0490.6-0.11%409
04/2447,66221.04030.01000.0490.70.55%231
04/23-637,65821.03030.01000.0490.22.50%372
04/22-557,72121.2030.0110.180.0488-1.12%548
04/1927,77621.35030.0120.210.0489-4.91%954
04/18117,77421.35030.01000.0493.61.08%236
04/17-197,76321.32-2030.01000.0492.61.76%556
04/162457,78221.3717230.06000.391-3.29%1,161
04/15307,53720.7260.02000.0894.1-3.09%1,076
04/12-17,50720.61140.01000.0597.1-0.82%559
04/11-37,50820.62-230.01000.0497.9-0.91%446
04/10-157,51120.62050.01000.0798.81.23%536
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
05/22300-36@Limit20.0220550-354,39094.1-1.05%415
05/21310-29@Limit20.029750-664,42595.1-1.86%454
05/20200-211@Limit20.0322680-464,49196.9-1.02%802
05/17060613@Limit20.0441600-194,53797.92.94%1,432
05/1611007@Limit20.0223380-154,55695.11.28%777
05/15200-27@Limit20.029410-324,57193.9-0.42%550
05/1404049@Limit20.02121410804,60394.31.84%1,501
05/1301015@Limit20.0121040-1024,52392.6-0.75%319
05/10100-14@Limit20.0191090-1004,62593.30.00%219
05/09100-15@Limit20.0115910-764,72593.3-0.74%251
05/08200-26@Limit20.0222660-2644,801941.29%349
05/0702028@Limit20.025410-365,06592.8-0.64%270
05/06210-16@Limit20.0291760-1675,10193.4-0.43%348
05/03100-17@Limit20.028240-165,26893.8-1.16%247
05/0202028@Limit20.02112320-2215,28494.91.28%504
04/30200-26@Limit20.02270-55,50593.7-1.68%283
04/2916058@Limit20.0248100385,51095.34.15%764
04/2600003@Limit20.01311390-1085,47291.50.99%318
04/2500003@Limit20.0160610-15,58090.6-0.11%409
04/2400003@Limit20.0120470-275,58190.70.55%231
04/2300003@Limit20.01149055,60890.22.50%372
04/2200003@Limit20.0171810-105,60388-1.12%548
04/1911003@Limit20.011701840-145,61389-4.91%954
04/1800003@Limit20.0119450-265,62793.61.08%236
04/172110-203@Limit20.0151300-1255,65392.61.76%556
04/1611801723@Limit20.06104650395,77891-3.29%1,161
04/1513026@Limit20.021754001355,73994.1-3.09%1,076
04/1201014@Limit20.01671050-385,60497.1-0.82%559
04/11200-23@Limit20.0145740-295,64297.9-0.91%446
04/1000005@Limit20.0116760-605,67198.81.23%536
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
05/22393,699,4003,704,9009.4141.03
05/21646,134,8006,161,70014.1420.31
05/2029829,114,70029,101,20037.16-45.3
05/1743142,026,90042,177,10030.1348.49
05/1620319,331,80019,375,80026.13216.75
05/1518917,846,80017,867,60034.36110.05
05/1464661,830,00061,771,40043.04-90.71
05/13373,425,5003,431,10011.6151.35
05/10201,862,0001,862,1009.135
05/09413,850,8003,859,60016.33214.63
05/08423,926,3003,938,70012.03295.24
05/07383,534,5003,544,30014.07257.89
05/06312,908,2002,911,8008.91116.13
05/03928,719,0008,693,30037.25-279.35
05/0216415,439,60015,482,90032.54264.02
04/30938,808,6008,806,90032.86-18.28
04/2914313,389,80013,460,60018.72495.1
04/26615,590,6005,607,80019.18281.97
04/2515113,814,00013,800,20036.92-91.39
04/24585,264,7005,265,30025.1110.34
04/23706,280,3006,294,70018.82205.71
04/2216114,285,30014,300,60029.3895.03
04/1919717,677,00017,715,40020.65194.92
04/18494,549,3004,571,50020.76453.06
04/1715114,017,50014,072,60027.16364.9
04/1620919,223,10019,270,80018228.23
04/1519218,202,90018,224,40017.84111.98
04/1211711,399,50011,394,40020.93-43.59
04/1111911,689,00011,693,90026.6841.18
04/1011010,884,30010,887,40020.5228.18
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章